90769007
Jun 11, 2021
Aug 2, 2022
Active Trademark
Pharmaceutical preparations, namely, for the activation of PKR (pyruvate kinase R), for the activation of PKM2 (pyruvate kinase isozyme M2), and for the prevention and treatment of blood disorders, pyruvate kinase deficiency (PKD), genetically defined diseases affecting red blood cells, hemolytic anemia
Pharmaceuticals